NewSpring, a private equity firm, led a $43m round in AeroSafe Global, a biopharma company, with participation from Peloton Equity, Merck Global Health Innovation Fund, Hamilton Lane, Flexstone Capital, Wave Equity Partners, and Escalate Capital. "We are thrilled to welcome NewSpring to the AeroSafe team. With their depth of knowledge, extensive experience, and outstanding team, NewSpring is the ideal partner for AeroSafe at this time of explosive growth in existing and expanding markets," Jay McHarg, AeroSafe CEO.